EFSA finds no safety concern for SweeGen’s non‐GMO rebaudioside M
Stevia-based sweetener company SweeGen has announced that the European Food Safety Authority (EFSA) food additive and flavoring panel found no safety concerns for its bioconverted rebaudioside M (reb M) stevia leaf sweetener.
Stevia-based sweetener company SweeGen has announced that the European Food Safety Authority (EFSA) food additive and flavoring panel found no safety concerns for its bioconverted rebaudioside M (reb M) stevia leaf sweetener. Final EFSA approval is expected in 2020.
SweeGen is the first company to receive the EFSA panel’s safety status for any steviol glycoside produced by alternative technologies. To achieve high purity clean-tasting and non‐GMO stevia leaf sweeteners, SweeGen uses an enzymatic bioconversion process starting with stevia leaf extract. This process enabled SweeGen to obtain the Non‐GMO Project verification for its Bestevia stevia sweeteners.
Press release (pdf)
More News
National Honey Board seeks honey–food pairings to encourage consumption of Mediterranean diet
The National Honey Board (NHB) is currently accepting pre-proposals for honey food-pairings to help Americans consume a Mediterranean diet pattern. Interested researchers need to submit a short pre-proposal by November 13, 2020.
National Honey Board seeks honey–food pairings to encourage consumption of Mediterranean diet
The National Honey Board (NHB) is currently accepting pre-proposals for honey food-pairings to help Americans consume a Mediterranean diet pattern. Interested researchers need to submit a short pre-proposal by November 13, 2020.
FDA amends its procedures for dairy, infant formula firms exporting to China
The U.S. Food and Drug Administration (FDA) is announcing changes to its export listing procedures for dairy and infant formula firms seeking to export their products to China.
FDA amends its procedures for dairy, infant formula firms exporting to China
The U.S. Food and Drug Administration (FDA) is announcing changes to its export listing procedures for dairy and infant formula firms seeking to export their products to China.
FDA announces qualified health claim for cranberry products and urinary tract infections
The U.S. FDA has announced in a letter of enforcement discretion that it does not intend to object to the use of certain qualified health claims regarding consuming certain cranberry products and a reduced risk of recurrent urinary tract infection in healthy women.
